Beitrag von Gerresheimer

Advantage for You! Swift access through small batch production is a game-changer. Our ability to produce with a high level of agility ensures sample stocks are readily available for your evaluation and testing needs. Efficiency at its finest! Learn more about: https://lnkd.in/gmg8yCve #innovatingforabetterlife #EfficientProduction #SmallBatchProduction #RapidResponse #pharma #biologics #drugdelivery

Don't miss our webinar! Join us for a discussion on drug commercialization and the role that packaging plays in ensuring a smooth transition to market. We support drug development from early phases to lifecycle management, offering regulatory and packaging expertise. Our Clinical Trial Kit is tailored for early-phase development of new drugs, vaccines, and biologics. It supports small-batch manufacturing from initial trials to clinical validation and is designed to accelerate drug development by providing sterile Gx® RTF vials in nest & tub or tray configurations with matching closures. Available in six configurations, with additional options like Gx® RTF COP vials coming soon, the kit offers ready-to-use solutions compatible with standard and automated filling lines. It ensures compliance with GMP requirements and can be customized with various stoppers and seals to accommodate high-value and demanding drugs. Register now to learn more about glass primary packaging and how our Clinical Trial Kit can enhance the efficiency of your drug development process: https://lnkd.in/gKaSPXUr

Our sustainability commitment goes far beyond reacting to raising expectations. We integrate sustainability in our business model in the way how we design processes, in the way how we rethink products and in the DNA of our decision making. Learn more about the Gerresheimer sustainability strategy. Link: https://lnkd.in/eDeeuyGe #innovatingforabetterlife #sustainability #pharma #biotech #healthcare #cosmetics

In the first half-year of 2024 revenue grew organically by 1.7%, adjusted EBITDA by 2.9%. For the 2nd half of FY 2024, Gerresheimer expects a significant upturn in business owing to new production lines ramping up and destocking effects fading out. Guidance for 2024 (organic) - Revenue growth: 5 - 10% - Adjusted EBITDA: EUR 430m - 450m - Adjusted EPS growth: 8 -12% Read our Half-year financial report https://lnkd.in/e8dQc6At #H1results #innovatingforabetterlife #gerresheimer #GLP1 #biologics #pharma #cosmetics #drugdelivery 

Gerresheimer remains on track for financial year 2024 and confirms the guidance. Revenues in the first half year of 2024 reached EUR 968.5m, adjusted EBITDA EUR 188.2m. Destocking effects for customers in the Primary Packaging Glass division were offset by the good revenue performance with a significantly improved margin in the Plastics & Devices division. Read our Corporate News https://lnkd.in/g8Bgy5e7 #H1results #innovatingforabetterlife #gerresheimer #GLP1 #biologics #pharma #cosmetics #drugdelivery

"We offer the right solution for all active ingredients, therapeutic areas and production requirements," says Holger Krenz, Global Vice President Business Development High Value Products Tubular Glass, "The new performance levels give our customers a transparent overview of our portfolio, making it easier to choose the right product." There are three performance levels within each product category: Gx Value, Gx Advance and Gx Elite. They make it easier for pharmaceutical and biotech companies to choose the right product platform for the specific requirements of the active pharmaceutical ingredient or the area of application. The Gx Elite product version offers the highest quality and is particularly suitable for innovative biopharmaceutical drugs. Find the right solution for your needs! Learn more about: https://lnkd.in/evAEfY-2 #innovatingforabetterlife #vails #syringes #ampoules #cartrigdes #pharma #biotech #drugpackaging

We cordially invite you to visit us at ADLM 2024 Clinical Lab Expo, the premier global laboratory medicine exposition, booth #1568, in Chicago. There you will have the opportunity to experience how we turn your visions into market-ready products using various laboratory disposables and medical devices. Gerresheimer Medical Systems is your one-stop-shop that can help you accelerate your time to market for any medical device. Use promo code “43148E” for your free clinical lab expo pass: https://lnkd.in/gabUT87H. We look forward to seeing you in Chicago and discussing your next diagnostic project. #innovatingforabetterlife #adlm #medicaldevices #laboratorydisposables

We will publish our half-year report on our website on July 11 in the morning at 7 am CEST: https://lnkd.in/e8dQc6At

What is the purpose in regards to the requested amounts? Gerresheimer is proud to be your partner regardless of whether you look for a packaging for clinical trials, a niche market, or high-quantity market. Knowing the requested amounts helps our product selector g guide, which combines state-of-the-art online customer service with the expertise of the Gerresheimer team in a digital tool, to leads you to your perfect packaging solution. Click here to check it out! https://lnkd.in/eennw2NG #innovatingforabetterlife #productselector #gguide #sales #pharma #biotech #biopharma #veterinary

Gerresheimer Syringes for Ophthalmic: More than meets the eye.   Did you know, that Gerresheimer is the preferred partner in the area of ophthalmic injectables offering the broadest portfolio of syringe configurations made of glass and polymers, metal-free or tungsten-reduced, either as baked-on-siliconized or silicone-oil-free options?  Comprehensive testing data available on request: https://lnkd.in/d3BNkiVS #innovatingforabetterlife #ophthalmic #injectables #pharma #biotech